Contact your prescribing healthcare professional immediately, as they may recommend temporary dose reduction, additional anti-nausea medication, or alternative management strategies to help you through the adjustment period
Kelly MS, Scopelliti EM, Goodson KE, Cma L, Nguyen HX, Simon B
Document any skin changes with photographs and notes about timing, location, and associated symptoms
GLP-1 receptor agonists | Prescribing information | Diabetes - type 2 | CKS | NICE
Just recently approved by Health Canada in January 2026, Rybelsus is the first and only once-daily GLP-1 tablet option for managing diabetes in Canada. Provincial Insurance Coverage: Who Gets Help Paying
It already is innovating products tailored for different stages of their weight loss journey and daily lives, including the recently launched Oikos Fusion and Oikos Protein Shakes